Key result
MRI/CT-guided mapping is linked to ~34% shorter procedures and improved VT freedom vs institutional ablation.
Why the study?
Functional substrate mapping techniques are increasingly used in clinical practice but can involve protracted mapping and procedure times.
Does integrating MRI/CT imaging with functional mapping reduce procedural time and improve outcomes in patients with post-infarct VT compared to conventional ablation strategies?
Cohort (n=166)
Yes
Does integrating MRI/CT imaging with functional mapping reduce procedural time and improve outcomes in patients with post-infarct VT compared to conventional ablation strategies?
Integrating MRI/CT scar imaging into functional mapping for post-infarct VT ablation reduces procedural time and improves clinical outcomes compared to conventional mapping.
Answers are grounded in this paper and cite their sources.
May shorten post-MI VT ablation time with better freedom from VT; hypothesis-generating, requiring randomized confirmation before practice change.
BACKGROUND: Functional substrate mapping techniques are increasingly utilised in clinical practice but can involve protracted mapping and procedure time. OBJECTIVE: We incorporated magnetic resonance imaging (MRI) and computed tomography (CT) derived ventricular scar data into the functional mapping workflow to assess the efficacy and outcome compared to conventional ablation strategies. METHODS: In this prospective multicenter registry, 166 patients with post-infarct Ventricular Tachycardia (VT) were enrolled into a prospective propensity matched registry. Cardiac MRI/CT scans were performed to target focused regions for functional mapping and ablation (Sense2). This was compared to a group that underwent mapping without image guidance (Sense) and a group that underwent activation/entrainment or substrate guided mapping and ablation without functional mapping or image guidance (Institutional). RESULTS: In the Sense2 group (145.8±28.7 mins), the mean procedural time was significantly shorter compared to the Sense group (171.0±51.1 mins) and Institutional group (221.4±73.9 mins), (p<0.0001). Similarly, mapping time was shorter (25.4 ± 7.3mins) compared to Sense (47.2 ± 8.9). Ablation time was significantly reduced in the Sense2 (18.1±11.6 mins) compared to the Sense (21.6±12.7 mins) and to the Institutional (25.9±13.9 mins) (p=0.006). Patients in the Sense2 and Sense had higher freedom from VT (p<0.001 for both) and improved survival (p<0.05 for both) compared to Institutional group. CONCLUSION: Sense2, integrating imaging with functional mapping, reduced the procedural times by enabling focused substrate maps to be performed and improved outcomes in terms of VT freedom compared to Institutional ablation. The improved survival requires corroborating with multi- centre randomized trials.
No takes yet. Share an insight, caveat, or question.
Παπαγεωργίου et al. (2026) conducted a cohort in post-infarct Ventricular Tachycardia (n=166). Sense2 (MRI/CT image-guided functional mapping and ablation) vs. Sense (mapping without image guidance) and Institutional ablation was evaluated on Mean procedural time (p=<0.0001). MRI/CT image-guided functional mapping (Sense2) reduced mean procedural time and improved freedom from VT compared to institutional ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: